Skip to main navigation Skip to search Skip to main content

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction

Project: Research project

Project Details

StatusActive
Effective start/end date6/9/26 → 9/30/36

Funding

  • TENAX THERAPEUTICS, INC